Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI, IUI, Surrogacy), and End User – Global Forecast to 2020

“The global infertility treatment devices market is expected to reach USD 3,698.92 million by 2020 from USD 1,822.32 million in 2015, at a CAGR of 15.21% between 2015 and 2020. By product, the market includes antivibration tables, cryosystems, gas analyzers, imaging systems, incubators, laser systems, micromanipulator systems, ovum aspiration pumps, sperm analyzer systems, workstations, and accessories. Based on technology, the market is segmented into in vitro fertilization, artificial insemination, gamete donation, intracytoplasmic sperm injection, intrauterine insemination, and surrogacy. The imaging systems segment accounts for the largest share of the infertility treatment devices market in 2015, while the sperm analyzer systems segment is expected to grow at the highest rate.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share of the global infertility treatment devices market in 2015, while Asia is poised to witness highest growth rate.

Market growth is majorly driven by the rising infertility rate among couples and single women. Other growth factors include increasing healthcare expenditure, increasing lifestyle disorders, and rising consumption of alcohol and cigarettes.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global infertility treatment devices market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
• Product Development: Product portfolios of the top players in the infertility treatment devices market
• Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the infertility treatment devices market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various infertility treatment devices products and services across geographies
”

“TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKETS COVERED 15
1.3.1 YEARS CONSIDERED IN THE REPORT 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.2.1 KEY DATA FROM SECONDARY SOURCES 22
2.2.2 KEY DATA FROM PRIMARY SOURCES 22
2.2.3 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL INFERTILITY TREATMENT DEVICES MARKET 28
4.2 LIFE CYCLE ANALYSIS, BY REGION (2015–2020) 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET SEGMENTATION 33
5.2.1 BY PRODUCT 33
5.2.2 BY TECHNOLOGY 33
5.2.3 BY END USER 34
5.3 MARKET DYNAMICS 34
5.3.1 DRIVERS 35
5.3.1.1 Decreasing fertility rate 35
5.3.1.2 Growth in healthcare expenditure 36
5.3.1.3 Increasing prevalence of lifestyle disorders 37
5.3.1.4 Rise in consumption of alcohol and cigarettes 37
5.3.2 RESTRAINTS 38
5.3.2.1 High cost of assisted reproductive techniques in developed markets 38
5.3.2.2 Restrictive regulations 38
5.3.3 OPPORTUNITIES 38
5.3.3.1 Low cost of assisted reproductive procedures in the Asian region 38
5.3.4 CHALLENGES 39
5.3.4.1 Reducing efficacy of infertility treatment with advancing age 39
6 INFERTILITY TREATMENT DEVICES MARKET, BY PRODUCT 40
6.1 INTRODUCTION 41
6.2 IMAGING SYSTEMS 43
6.3 SPERM ANALYZER SYSTEMS 44
6.4 WORKSTATIONS 46
6.5 OVUM ASPIRATION PUMPS 48
6.6 INCUBATORS 49
6.7 MICROMANIPULATOR SYSTEMS 51
6.8 GAS ANALYZERS 53
6.9 LASER SYSTEMS 54
6.10 CRYOSYSTEMS 56
6.11 ANTIVIBRATION TABLES 58
6.12 ACCESSORIES 59
7 INFERTILITY TREATMENT DEVICES MARKET, BY TECHNOLOGY 62
7.1 INTRODUCTION 63
7.2 IN VITRO FERTILIZATION 64
7.3 ARTIFICIAL INSEMINATION 66
7.4 INTRAUTERINE INSEMINATION 68
7.5 INTRACYTOPLASMIC SPERM INJECTION 70
7.6 GAMETE DONATION 72
7.7 SURROGACY 74
8 INFERTILITY TREATMENT DEVICES MARKET, BY END USER 77
8.1 INTRODUCTION 78
8.2 FERTILITY AND SURGICAL CENTERS 79
8.3 HOSPITALS AND CLINICS 81
8.4 CRYOBANKS 83
9 INFERTILITY TREATMENT DEVICES MARKET, BY REGION 86
9.1 INTRODUCTION 87
9.2 NORTH AMERICA 89
9.2.1 U.S. 95
9.2.2 CANADA 98
9.3 EUROPE 101
9.4 ASIA 106
9.5 REST OF THE WORLD (ROW) 110

10 COMPETITIVE LANDSCAPE 115
10.1 INTRODUCTION 115
10.2 STRATEGIC OVERVIEW 115
10.3 LEADING PLAYERS IN THE INFERTILITY TREATMENT DEVICES MARKET 116
10.4 COMPETITIVE SITUATION AND TRENDS 117
10.4.1 NEW PRODUCT LAUNCHES 117
10.4.2 EXPANSIONS 119
10.4.3 ACQUISITIONS 120
10.4.4 COLLABORATIONS 120
10.4.5 OTHER DEVELOPMENTS 121
11 COMPANY PROFILES 122
11.1 INTRODUCTION 122
11.2 THE COOPER COMPANIES, INC. 123
11.3 COOK GROUP INCORPORATED 127
11.4 THERMO FISHER SCIENTIFIC, INC. 129
11.5 VITROLIFE AB 132
11.6 RESEARCH INSTRUMENTS LIMITED 135
11.7 ESCO MICRO PTE. LTD. 136
11.8 GENEA LIMITED 137
11.9 IRVINE SCIENTIFIC 138
11.10 IVFTECH APS 139
11.11 THE BAKER COMPANY, INC. 140
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted 

Companies.
12 APPENDIX 141
12.1 INSIGHTS OF INDUSTRY EXPERTS 141
12.2 DISCUSSION GUIDE 142
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144
12.4 AVAILABLE CUSTOMIZATIONS 145
12.5 RELATED REPORTS 146
“
“LIST OF TABLES

TABLE 1 INFERTILITY TREATMENT DEVICES MARKET SUMMARY 24
TABLE 2 DECREASING FERTILITY RATE ALONG WITH INCREASE IN HEALTHCARE EXPENDITURE IS PROPELLING THE GROWTH OF THE INFERTILITY TREATMENT DEVICES MARKET 37
TABLE 3 HIGH COST OF ASSISTED REPRODUCTIVE TECHNIQUES TO RESTRICT MARKET GROWTH 38
TABLE 4 LOW COST OF ASSISTED REPRODUCTIVE PROCEDURES IN ASIAN REGION PRESENTS SIGNIFICANT GROWTH OPPORTUNITIES FOR THE MARKET 39
TABLE 5 REDUCING EFFICACY OF INFERTILITY TREATMENT WITH ADVANCING AGE IS A MAJOR CHALLENGE FOR THE INFERTILITY TREATMENT DEVICES MARKET 39
TABLE 6 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2013–2020 (USD MILLION) 42
TABLE 7 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR IMAGING SYSTEMS, 
BY REGION, 2013–2020 (USD MILLION) 44
TABLE 8 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR IMAGING SYSTEMS, BY COUNTRY, 2013–2020 (USD MILLION) 44
TABLE 9 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR SPERM ANALYZER SYSTEMS,  BY REGION, 2013–2020 (USD MILLION) 45
TABLE 10 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR SPERM ANALYZER SYSTEMS, BY COUNTRY, 2013–2020 (USD MILLION) 46
TABLE 11 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR WORKSTATIONS, 
BY REGION,  2013–2020 (USD MILLION) 47
TABLE 12 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR WORKSTATIONS,  BY COUNTRY, 2013–2020 (USD MILLION) 48
TABLE 13 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR OVUM ASPIRATION PUMPS,  BY REGION, 2013–2020 (USD MILLION) 49
TABLE 14 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR OVUM ASPIRATION PUMPS, BY COUNTRY, 2013–2020 (USD MILLION) 49
TABLE 15 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR INCUBATORS, BY REGION,  2013–2020 (USD MILLION) 50
TABLE 16 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR INCUBATORS,  BY COUNTRY, 2013–2020 (USD MILLION) 51
TABLE 17 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR MICROMANIPULATOR SYSTEMS,  BY REGION, 2013–2020 (USD MILLION) 52
TABLE 18 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR MICROMANIPULATOR SYSTEMS, BY COUNTRY, 2013–2020 (USD MILLION) 53
TABLE 19 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR GAS ANALYZERS, 
BY REGION,  2013–2020 (USD MILLION) 54
TABLE 20 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR GAS ANALYZERS,  BY COUNTRY, 2013–2020 (USD MILLION) 54
TABLE 21 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR LASER SYSTEMS, 
BY REGION,  2013–2020 (USD MILLION) 55
TABLE 22 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR LASER SYSTEMS,  BY COUNTRY, 2013–2020 (USD MILLION) 56
TABLE 23 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR CRYOSYSTEMS, BY REGION,  2013–2020 (USD MILLION) 57
TABLE 24 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR CRYOSYSTEMS,  BY COUNTRY, 2013–2020 (USD MILLION) 57
TABLE 25 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR ANTIVIBRATION TABLES, 
BY REGION, 2013–2020 (USD MILLION) 58
TABLE 26 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR ANTIVIBRATION TABLES, BY COUNTRY, 2013–2020 (USD MILLION) 59
TABLE 27 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR ACCESSORIES, BY REGION,  2013–2020 (USD MILLION) 60
TABLE 28 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET FOR ACCESSORIES,  BY COUNTRY, 2013–2020 (USD MILLION) 61
TABLE 29 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  
2013–2020 (USD MILLION) 64
TABLE 30 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR IN VITRO FERTILIZATION, 
BY REGION, 2013–2020 (USD MILLION) 65
TABLE 31 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR IN VITRO FERTILIZATION, BY COUNTRY, 2013–2020 (USD MILLION) 66
TABLE 32 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR ARTIFICIAL INSEMINATION,  BY REGION, 2013–2020 (USD MILLION) 67
TABLE 33 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR ARTIFICIAL INSEMINATION, BY COUNTRY, 2013–2020 (USD MILLION) 68
TABLE 34 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR INTRAUTERINE INSEMINATION,  BY REGION, 2013–2020 (USD MILLION) 69
TABLE 35 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR INTRAUTERINE INSEMINATION, BY COUNTRY, 2013–2020 (USD MILLION) 70
TABLE 36 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2013–2020 (USD MILLION) 71
TABLE 37 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2013–2020 (USD MILLION) 72
TABLE 38 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR GAMETE DONATION, 
BY REGION, 2013–2020 (USD MILLION) 73
TABLE 39 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR GAMETE DONATION, BY COUNTRY, 2013–2020 (USD MILLION) 74
TABLE 40 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR SURROGACY, BY REGION,  2013–2020 (USD MILLION) 75
TABLE 41 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR SURROGACY,  BY COUNTRY, 2013–2020 (USD MILLION) 76
TABLE 42 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER, 
 2013–2020 (USD MILLION) 79
TABLE 43 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR FERTILITY AND SURGICAL CENTERS, BY REGION, 2013–2020 (USD MILLION) 80
TABLE 44 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR FERTILITY AND SURGICAL CENTERS, BY COUNTRY, 2013–2020 (USD MILLION) 81
TABLE 45 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR HOSPITALS AND CLINICS,  
BY REGION, 2013–2020 (USD MILLION) 82
TABLE 46 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2013–2020 (USD MILLION) 83
TABLE 47 INFERTILITY TREATMENT DEVICES MARKET SIZE FOR CRYOBANKS, BY REGION,  2013–2020 (USD MILLION) 84
TABLE 48 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE FOR CRYOBANKS,  BY COUNTRY, 2013–2020 (USD MILLION) 85
TABLE 49 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY REGION, 
2013–2020 (USD MILLION) 88
TABLE 50 NORTH AMERICA INFERTILITY TREATMENT DEVICES MARKET SIZE, BY REGION,  2013–2020 (USD MILLION) 91
TABLE 51 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  2013–2020 (USD MILLION) 92
TABLE 52 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE, 
BY TECHNOLOGY,  2013–2020 (USD MILLION) 93
TABLE 53 NORTH AMERICA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER,  2013–2020 (USD MILLION) 94
TABLE 54 U.S.: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 
 2013–2020 (USD MILLION) 96
TABLE 55 U.S.: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  
2013–2020 (USD MILLION) 96
TABLE 56 U.S.: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER,  
2013–2020 (USD MILLION) 97
TABLE 57 CANADA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2013–2020 (USD MILLION) 99
TABLE 58 CANADA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  2013–2020 (USD MILLION) 100
TABLE 59 CANADA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER,  
2013–2020 (USD MILLION) 100
TABLE 60 EUROPE: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2013–2020 (USD MILLION) 103
TABLE 61 EUROPE: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  2013–2020 (USD MILLION) 104
TABLE 62 EUROPE: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER,  
2013–2020 (USD MILLION) 105
TABLE 63 ASIA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2013–2020 (USD MILLION) 108
TABLE 64 ASIA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  
2013–2020 (USD MILLION) 109
TABLE 65 ASIA: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER,  
2013–2020 (USD MILLION) 110
TABLE 66 ROW: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2013–2020 (USD MILLION) 112
TABLE 67 ROW: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  
2013–2020 (USD MILLION) 113
TABLE 68 ROW: INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER, 
 2013–2020 (USD MILLION) 114
TABLE 69 RANK OF COMPANIES IN THE GLOBAL INFERTILITY TREATMENT DEVICES 
MARKET, 2015 116
TABLE 70 MARKET DEVELOPMENTS BETWEEN 2013 AND 2015 117
TABLE 71 NEW PRODUCT LAUNCHES, 2013–2015 118
TABLE 72 EXPANSIONS, 2013–2015 119
TABLE 73 ACQUISITIONS, 2013–2015 120
TABLE 74 COLLABORATIONS, 2013–2015 120
TABLE 75 OTHER DEVELOPMENTS, 2013–2015 121
“
“LIST OF FIGURES

FIGURE 1 INFERTILITY TREATMENT DEVICES MARKET 15
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, 
AND REGION 20
FIGURE 6 DATA TRIANGULATION METHODOLOGY 21
FIGURE 7 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY PRODUCT,  
2015 VS. 2020 (USD MILLION) 25
FIGURE 8 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY,  
2015 VS. 2020 (USD MILLION) 25
FIGURE 9 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER, 
2015 VS. 2020 (USD MILLION) 26
FIGURE 10 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY REGION,  
2015 VS. 2020 (USD MILLION) 27
FIGURE 11 GLOBAL INFERTILITY TREATMENT DEVICES MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 28
FIGURE 12 FERTILITY AND SURGICAL CENTERS END-USER SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 29
FIGURE 13 ASIA TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020 30
FIGURE 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 31
FIGURE 15 INFERTILITY TREATMENT DEVICES MARKET SEGMENTATION, BY PRODUCT 33
FIGURE 16 INFERTILITY TREATMENT DEVICES MARKET SEGMENTATION, BY TECHNOLOGY 33
FIGURE 17 INFERTILITY TREATMENT DEVICES MARKET SEGMENTATION, BY END USER 34
FIGURE 18 INFERTILITY TREATMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 19 DECREASE IN THE GLOBAL FERTILITY RATE TO DRIVE THE INFERTILITY TREATMENT DEVICES MARKET 36
FIGURE 20 INCREASE IN THE GLOBAL HEALTHCARE EXPENDITURE TO DRIVE THE INFERTILITY TREATMENT DEVICES MARKET 36
FIGURE 21 INFERTILITY TREATMENT DEVICES MARKET SEGMENTATION, BY PRODUCT 41
FIGURE 22 INFERTILITY TREATMENT DEVICES MARKET, BY PRODUCT,  2015 VS. 2020 (USD MILLION) 42
FIGURE 23 NORTH AMERICA EXPECTED TO BE THE LARGEST REGIONAL SEGMENT FOR IMAGING SYSTEMS BY 2020 43
FIGURE 24 ASIA, THE FASTEST-GROWING REGIONAL MARKET FOR SPERM ANALYZER SYSTEMS BETWEEN 2015 TO 2020 45
FIGURE 25 NORTH AMERICA DOMINATES WORKSTATIONS MARKET IN 2015 47
FIGURE 26 NORTH AMERICA EXPECTED TO BE THE LARGEST REGIONAL MARKET FOR OVUM ASPIRATION PUMPS BY 2020 48
FIGURE 27 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE INCUBATORS MARKET IN 2015 50
FIGURE 28 NORTH AMERICA EXPECTED TO BE THE LARGEST REGIONAL MARKET FOR MICROMANIPULATOR SYSTEMS BY 2020 52
FIGURE 29 ASIA IS THE FASTEST-GROWING REGIONAL MARKET FOR GAS ANALYZERS BETWEEN 2015 TO 2020 53
FIGURE 30 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE FOR LASER SYSTEMS 
IN 2015 55
FIGURE 31 NORTH AMERICA EXPECTED TO BE THE LARGEST REGIONAL MARKET FOR CRYOSYSTEMS BY 2020 56
FIGURE 32 ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT FOR ANTIVIBRATION TABLES BETWEEN 2015 TO 2020 58
FIGURE 33 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE ACCESSORIES MARKET IN 2015 60
FIGURE 34 INFERTILITY TREATMENT DEVICES MARKET SEGMENTATION, BY TECHNOLOGY 63
FIGURE 35 INFERTILITY TREATMENT DEVICES MARKET, BY TECHNOLOGY, 
 2015 (USD MILLION) 63
FIGURE 36 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE IN VITRO FERTILIZATION SEGMENT BY 2020 65
FIGURE 37 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE ARTIFICIAL INSEMINATION SEGMENT IN 2015 67
FIGURE 38 ASIA TO WITNESS HIGHEST GROWTH OF THE INTRAUTERINE INSEMINATION SEGMENT BETWEEN 2015–2020 69
FIGURE 39 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE INTRACYTOPLASMIC SPERM INJECTION SEGMENT BY 2020 71
FIGURE 40 NORTH AMERICA IS EXPECTED TO BE THE LARGEST SEGMENT OF THE GAMETE DONATION SEGMENT IN 2015 73
FIGURE 41 ASIA TO WITNESS HIGHEST GROWTH OF THE SURROGACY SEGMENT BY 2020 75
FIGURE 42 INFERTILITY TREATMENT DEVICES MARKET, BY END USER 78
FIGURE 43 INFERTILITY TREATMENT DEVICES MARKET SIZE, BY END USER, 
2015 (USD MILLION) 78
FIGURE 44 FERTILITY AND SURGICAL CENTERS SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA BY 2020 80
FIGURE 45 NORTH AMERICA IS EXPECTED TO BE THE LARGEST SEGMENT OF THE HOSPITALS AND CLINICS SEGMENT IN 2015 82
FIGURE 46 CRYOBANKS SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN  
2015 AND 2020 84
FIGURE 47 ASIA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 87
FIGURE 48 GEOGRAPHIC SNAPSHOT (2015) 88
FIGURE 49 NORTH AMERICA: MACRO INDICATORS 89
FIGURE 50 NORTH AMERICA: MARKET SNAPSHOT 90
FIGURE 51 NORTH AMERICAN GEOGRAPHIC SNAPSHOT (2015) 91
FIGURE 52 SPERM ANALYZER SYSTEMS EXPECTED TO HOLD LARGEST SHARE OF NORTH AMERICAN MARKET, BY PRODUCT, IN 2020 92
FIGURE 53 IN VITRO FERTILIZATION, THE DOMINANT TECHNOLOGY SEGMENT IN 2015 93
FIGURE 54 FERTILITY AND SURGICAL CENTERS TO BE THE LARGEST END-USER SEGMENT OF THE NORTH AMERICAN INFERTILITY TREATMENT DEVICES MARKET IN 2015 94
FIGURE 55 U.S.: MACRO INDICATORS 95
FIGURE 56 CANADA: MACRO INDICATORS 98
FIGURE 57 EUROPE: MACRO INDICATORS 101
FIGURE 58 SPERM ANALYZER SYSTEMS EXPECTED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPE MARKET BY 2020 102
FIGURE 59 IN VITRO FERTILIZATION TO BE THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2015 103
FIGURE 60 FERTILITY AND SURGICAL CENTERS TO BE THE LARGEST END-USER SEGMENT OF THE EUROPEAN INFERTILITY TREATMENT DEVICES MARKET IN 2015 104
FIGURE 61 ASIA: MACRO INDICATORS 106
FIGURE 62 ASIA: MARKET SNAPSHOT 107
FIGURE 63 IMAGING SYSTEMS SEGMENT DOMINATES ASIAN MARKET IN 2015 108
FIGURE 64 IN VITRO FERTILIZATION TO BE THE LARGEST TECHNOLOGY SEGMENT IN ASIA
 IN 2015 109
FIGURE 65 FERTILITY AND SURGICAL CENTERS, THE LARGEST END-USER SEGMENT IN 2015 110
FIGURE 66 ROW: MACRO INDICATORS 111
FIGURE 67 SPERM ANALYZER SYSTEMS PRODUCT SEGMENT EXPECTED TO COMMAND LARGEST MARKET SHARE IN 2015 112
FIGURE 68 IN VITRO FERTILIZATION TO BE THE LARGEST TECHNOLOGY SEGMENT IN ROW 
IN 2015 113
FIGURE 69 FERTILITY AND SURGICAL CENTERS TO BE THE LARGEST END-USER SEGMENT OF THE ROW INFERTILITY TREATMENT DEVICES MARKET IN 2015 114
FIGURE 70 KEY DEVELOPMENTS IN THE INFERTILITY TREATMENT DEVICES MARKET, 
2013-2015 115
FIGURE 71 GEOGRAPHIC PRESENCE  OF THE TOP FIVE MARKET PLAYERS 122
FIGURE 72 COMPANY SNAPSHOT: THE COOPER COMPANIES, INC. 123
FIGURE 73 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 129
FIGURE 74 COMPANY SNAPSHOT: VITROLIFE AB 132
“